Creative Planning Siga Technologies Inc Transaction History

Creative Planning

  • $129 Billion
  • Q3 2025

A detailed history of Creative Planning transactions in Siga Technologies Inc stock. As of the latest transaction made, Creative Planning holds 56,959 shares of SIGA stock, worth $341,754. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,959
Previous 34,546 64.88%
Holding current value
$341,754
Previous $225,000 131.56%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$6.46 - $9.48 $144,787 - $212,475
22,413 Added 64.88%
56,959 $521,000
Q2 2025

Aug 08, 2025
SELL
$5.22 - $6.56 $16,396 - $20,604
-3,141 Reduced 8.33%
34,546 $225,000
Q1 2025

May 15, 2025
SELL
$5.39 - $6.47 $8,408 - $10,093
-1,560 Reduced 3.97%
37,687 $206,000
Q4 2024

Feb 14, 2025
BUY
$5.73 - $7.72 $630 - $849
110 Added 0.28%
39,247 $235,000
Q3 2024

Oct 11, 2024
BUY
$6.74 - $11.97 $47,948 - $85,154
7,114 Added 22.22%
39,137 $263,000
Q2 2024

Aug 15, 2024
BUY
$6.32 - $10.46 $19,945 - $33,011
3,156 Added 10.93%
32,023 $243,000
Q1 2024

May 10, 2024
SELL
$4.51 - $8.92 $43,097 - $85,239
-9,556 Reduced 24.87%
28,867 $247,000
Q4 2023

Feb 14, 2024
BUY
$4.82 - $6.25 $55,748 - $72,287
11,566 Added 43.07%
38,423 $215,000
Q3 2023

Nov 16, 2023
BUY
$4.32 - $5.77 $116,022 - $154,964
26,857 New
26,857 $140,000
Q2 2021

Aug 04, 2021
SELL
$6.1 - $7.58 $61,183 - $76,027
-10,030 Closed
0 $0
Q2 2020

Jul 23, 2020
BUY
$4.55 - $6.19 $136 - $185
30 Added 0.3%
10,030 $59,000
Q2 2018

Jul 20, 2018
SELL
$5.89 - $7.29 $42,207 - $52,240
-7,166 Reduced 41.75%
10,000 $59,000
Q1 2018

Apr 18, 2018
BUY
$4.7 - $6.65 $80,680 - $114,153
17,166 New
17,166 $105,000

Others Institutions Holding SIGA

# of Institutions
213
Shares Held
35.1M
Call Options Held
74.6K
Put Options Held
22.8K
View Full List

About SIGA TECHNOLOGIES INC

SIGA Quotes by TradingView
  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $438M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email